Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care Test

The clinical performance of the BD Veritor System for Rapid Detection of SARS-CoV-2 nucleocapsid antigen (Veritor), a chromatographic immunoassay used for SARS-CoV-2 point-of-care testing, was evaluated using nasal specimens from individuals with COVID-19 symptoms. Two studies were completed to dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Stephen, Taylor, Stephanie N., Cammarata, Catherine L., Varnado, Katey G., Roger-Dalbert, Celine, Montano, Amanda, Griego-Fullbright, Christen, Burgard, Cameron, Fernandez, Catherine, Eckert, Karen, Andrews, Jeffrey C., Ren, Huimiao, Allen, Joseph, Ackerman, Ronald, Cooper, Charles K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Virology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771450/
https://www.ncbi.nlm.nih.gov/pubmed/33023911
http://dx.doi.org/10.1128/JCM.02338-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771450/
https://www.ncbi.nlm.nih.gov/pubmed/33023911
http://dx.doi.org/10.1128/JCM.02338-20

Ejemplares similares